Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Understanding Neural Physiology to Accelerate Advancement in Neural Health
- CNS 2018

About Confrence

Established in the year 1997, Allied Academies Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. 
Allied Academies invites all the participants from all over the world to attend "11th International Conference on Central Nervous System and Neurophysiology”, on November 14-15, 2018 in Rome, Italy which includes prompt keynote presentations, oral talks, poster presentations and exhibitions.
The Central Nervous System (CNS) is a very complex, highly organized structure. It consists of the brain in the skull and the spinal cord, which threads through holes down the middle of the vertebrae (bones that make up the vertebral column ["backbone"]). The front half (roughly) of the CNS organizes and controls movement; the back half receives and processes information from the senses. The CNS is organized as a hierarchy (organized in graded layers, higher layers controlling lower layers as in the military [general > colonel > major > lieutenant]). Each level from the cerebral hemispheres at the top controls the levels below it. Unlike most hierarchies, the higher the level the more parts to it, at least in the brains of mammals, especially humans. The hierarchy has three main levels, cerebral hemispheres > brain stem > spinal cord.
There are many central nervous system diseases and conditions, including infections of the central nervous system such as encephalitis and poliomyelitis, early-onset neurological disorders including ADHD and autism, late-onset neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and essential tremor, autoimmune and inflammatory diseases such as multiple sclerosis and acute disseminated encephalomyelitis, genetic disorders such as Krabbe's disease and Huntington's disease, as well as amyotrophic lateral sclerosis and adrenoleukodystrophy. Lastly, cancers of the central nervous system can cause severe illness and, when malignant, can have very high mortality rates. Symptoms depend on size, growth rate, location and malignancy of tumours and can include alterations in motor control, hearing loss, headaches and changes in cognitive ability and autonomic functioning. A wide range of treatments for central nervous system diseases is currently in progress, these can range from surgery to neural rehabilitation or prescribed medications.

Objective:
CNS 2018 is a platform to fulfil the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. CNS 2018 will have an anticipated participation of 120+ delegates across the world to discuss the conference goal.

About Organizers:
Allied Academies is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia.  Allied Academies has so far organized 3000+ Global Allied Academics  Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology.

Welcome Message

Allied Academies welcomes all the attendees, speakers, sponsor’s and other research expertise from all over the world to the "11th International Conference on Central Nervous System and Neurophysiology” (CNS-2018) which is going to be held during November 14-15, 2018 in Rome, Italy. We are very much honoured to invite you all to exchange and share your views and experience on CNS: Understanding Neural Physiology to Accelerate Advancement in Neural Health.
Allied Academies Organizes CNS-2018 conference along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities as editorial board members.
We invite you to join us at the CNS-2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the CNS-2018 organizing committee look forward to meeting you in Rome, Italy.

Sessions/Tracks

CNS 2018 will encompass recent researches and findings in CNS technologies, CNS disorders and therapeutics, current understanding of CND disorders and brain physiology and other advancements in CNS research and neuroscience. CNS 2018 will be a great platform for research scientists and young researchers to share their current findings in this field of basic and applied science. The major scientific sessions in CNS 2018 will focus on the latest and exciting innovations in prominent areas of neuroscience and CNS disorders diagnosis and treatment research.
The Central Nervous System (CNS) is a very complex, highly organized structure. It consists of the brain in the skull and the spinal cord, which threads through holes down the middle of the vertebrae (bones that make up the vertebral column ["backbone"]). The front half (roughly) of the CNS organizes and controls movement; the back half receives and processes information from the senses. The CNS is organized as a hierarchy (organized in graded layers, higher layers controlling lower layers as in the military. Each level from the cerebral hemispheres at the top controls the levels below it. Unlike most hierarchies, the higher the level the more parts to it, at least in the brains of mammals, especially humans. The hierarchy has three main levels, cerebral hemispheres > brain stem > spinal cord.

There are many central nervous system diseases and conditions, including infections of the central nervous system such as encephalitis and poliomyelitis, early-onset neurological disorders including ADHD and autism, late-onset neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and essential tremor, autoimmune and inflammatory diseases such as multiple sclerosis and acute disseminated encephalomyelitis, genetic disorders such as Krabbe's disease and Huntington's disease, as well as amyotrophic lateral sclerosis and adrenoleukodystrophy. Lastly, cancers of the central nervous system can cause severe illness and, when malignant, can have very high mortality rates. Symptoms depend on size, growth rate, location and malignancy of tumours and can include alterations in motor control, hearing loss, headaches and changes in cognitive ability and autonomic functioning. A wide range of treatments for central nervous system diseases is currently in progress; these can range from surgery to neural rehabilitation or prescribed medications.
Neurophysiology is the study of the functions of the nervous system. Clinical neurophysiology is the study of the functions of the nervous system in the clinical setting, for diagnostics, treatment, and intensive care purposes. It is a broad field of study because many different levels are involved in the overall functioning of the nervous system and its components. This involves studying the relationship and pathways between the brain and the organs of the body and the nerves that connect them, both sensory, meaning nerves that receive input from sensors, and motor, meaning the nerves that activate the muscle. Thus, neurophysiology studies nervous function ranging from individual nerve cells to the complex behaviours of the central nervous system. Additionally, the nervous system not only functions at the cell and system levels of the organization but also at a mechanistic level, that involves the study of the control or regulatory processes that occur.
Central Nervous System Diseases or Disorders are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). Every disease has its different signs and symptoms. Some of them are a persistent headache, pain in the face, back, arms, or legs, an inability to concentrate, loss of feeling, memory loss, loss of muscle strength, tremors, seizures, increased reflexes, spasticity, paralysis, and slurred speech. There is a wide range of treatments for central nervous system diseases. These can range from surgery to neural rehabilitation or prescribed medications.

Animal and Translational Models for CNS Drug Discovery combines the experience of academic, clinical and pharmaceutical neuroscientists in a unique collaborative approach to provide a greater understanding of the relevance of animal models of neuropsychiatric disorders and their role as translational tools for the discovery of CNS drugs being developed for the treatment of these disorders.

Multiple sclerosis (MS) is a chronic inflammatory, demyelinating central nervous system (CNS) disease involving cells of the adaptive and innate immune systems. This track covers the scientific basis of multiple sclerosis including etiology, epidemiology, and pathogenesis along with the diagnostic process, the course of the disease and prognosis, and the use of MRI in the diagnosis and disease monitoring. Disease-modifying treatment algorithms for relapsing-remitting multiple sclerosis, switching therapy, and progressive multiple sclerosis treatment algorithms are all discussed in detail. It also addresses multiple sclerosis in childhood and pregnancy and includes assessment of alternative therapies.

Metabolic and Degenerative Diseases of the CNS deals with the neuropathology of metabolic and neurodegenerative diseases of various etiologies that exhibit similar CNS changes on CT and MR images. The etiologies may be congenital (e. g., congenital metabolic diseases) or acquired (e.g., metabolic, inflammatory, toxic insults) and result in diffuse or (multi)focal degenerative changes in central nervous tissues.

Although multiple sclerosis and other disorders of myelin formation and repair are most commonly associated with adults, they can also occur in infants, children and adolescents. Up to 5 percent of those with MS experience symptoms before the age of 18, and the number of cases diagnosed is rising. There is a lack of awareness about these diseases in childhood, however, even amongst paediatric neurologists and MS specialists. This track aims at highlighting the differences between management in childhood and in adults pertaining to the diagnosis, course, treatment and biology of paediatric MS, other childhood demyelinating diseases, including acute disseminated encephalomyelitis, optic neuritis, acute complete transverse myelitis and neuromyelitis optica.

The human brain is a uniquely complex organ, which has self-evolved into a sophisticated protection system to prevent itself injury from external insults and toxins. Designing molecules that can overcome this protection system and achieve optimal concentration at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery. Over the time academic, clinical and pharmaceutical neuroscientists have been trying to provide a greater understanding of the relevance of animal models of neuropsychiatric disorders and their role as translational tools for the discovery of CNS drugs being developed for the treatment of these disorders. It includes the study of leading experts actively involved in the use of animal models for understanding the fundamental neurobiology of CNS disorders and the application of this knowledge to CNS drug discovery, and clinical investigators involved in clinical trials, drug development and eventual registration of novel pharmaceuticals.
 
The aim of Neuro Rehabilitation goes for enhancing patient function, overall life quality and lessens side effects. The medications or treatment help the patients in exercises of day to day living like eating, dressings, cooking and essential basic tasks. The speech therapy in the recovery program advances the patients perusing, composing and talking abilities. These recovery processes and therapeutic process centres around the recovery of Nervous or neural injuries. Various rehabilitative methodologies are developed and examined. A learning-based approach is supported to encourage neural plastic changes and restoration.
Speech Therapy
Paediatric Nursing
Neurosurgical Nursing
Critical Care Nursing
Clinical Nursing
Nursing Management

Injury to the central nervous system unlike peripheral nervous system injury is not followed by extensive regeneration. It is limited by the inhibitory influences of the glial and extracellular environment. The hostile, non-permissive growth environment is, in part, created by the migration of myelin-associated inhibitors, astrocytes, oligodendrocytes, oligodendrocyte precursors, and microglia. The environment within the CNS, especially following trauma, counteracts the repair of myelin and neurons. Growth factors are not expressed or re-expressed. Glial scars rapidly form, and the glia actually produces factors that inhibit re-myelination and axon repair. Pioneering work by Aguayo and colleagues demonstrated that adult mammalian CNS neurons, which normally do not regenerate, are able to grow for long distances into the permissive environment of a peripheral nerve graft (Richardson et al. 1980, 1984; David and Aguayo 1981; Benfey and Aguayo 1982). These studies demonstrated that the environment is a critical determinant of axon regeneration. Subsequently, numerous molecules were identified within the CNS that limit regeneration.

Biomarkers are measurable biological indicators that are used to diagnose or predict diseases, examine disease progression, and estimate treatment response. Biomarkers help in understanding the development of chronic diseases, its relationship with environmental chemicals, and identify subjects who are at high risk of developing the disease. Biomarkers have played a significant role in drug research and development of new drugs and in diagnostics. Moreover, biomarkers play important role in understanding disease mechanism, developing effective treatments, and improve quality of patient care. Considering the complexity of the central nervous system (CNS), biomarkers are now expected to play a significant role in the identification of several neurodegenerative diseases at an early stage, provide enhanced diagnosis, and eventually better treatment.


Electromyography (EMG) is a diagnostic procedure to assess the health of muscles and the nerve cells that control them (motor neurons). Motor neurons transmit electrical signals that cause muscles to contract. An EMG translates these signals into graphs, sounds or numerical values that a specialist interprets. An EMG uses tiny devices called electrodes to transmit or detect electrical signals. 

CNS and Brain Function
Neuropsychiatry and Neurological Disorders
Sensory and Motor Neuron Functions and Disorders
Cognitive Neurology
Neurogenetics and Molecular Biology of the Brain
Clinical Neurophysiology and Neurochemical Disorders
Clinical Neurophysiology of Sleep Disorders
Clinical Neurophysiology of Movement Disorders
Electricity and Electronics for Clinical Neurophysiology
Electric safety in Laboratory and Hospital
Electroencephalography: Neonates, Infants, Children and Adults
Clinical Applications: Assessing Central Nervous System Symptoms

Market Analysis Report

CNS 2018 is a platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. CNS 2018 will have an anticipated participation of 120+ attendees across the world to discuss the conference goal.

Why attend???
11th International Conference on Central Nervous System and Neurophysiology is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.
The aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

About Rome
Rome is the capital city of Italy and furthermore fills in as the capital of the Lazio locale. With 2,872,800 inhabitants in 1,285 km2 (496.1 sq mi), it is additionally the nation's most populated cooperative. It is the fourth-most crowded city in the European Union by populace inside city limits. It is the focal point of the Metropolitan City of Rome, which has a populace of 4.3 million occupants. Rome is situated in the focal western segment of the Italian Peninsula, inside Lazio (Latium), along the shores of the Tiber. The Vatican City is a free nation inside the city limits of Rome, the main existing case of a nation inside a city: therefore Rome has been frequently characterized as capital of two states.
Rome is in the Lazio district of focal Italy on the Tiber (Italian: Tevere) stream. The first settlement created on slopes that confronted onto a portage next to the Tiber Island, the main characteristic passage of the stream around there. The Rome of the Kings was based on seven slopes: the Aventine Hill, the Caelian Hill, the Capitoline Hill, the Esquiline Hill, the Palatine Hill, the Quirinal Hill, and the Viminal Hill. Present day Rome is additionally crossed by another stream, the Aniene, which streams into the Tiber north of the noteworthy focus.
Rome has a Mediterranean atmosphere (Köppen atmosphere order: Csa), with cool, sticky winters and warm, dry summers. Rome today is a standout amongst the most critical traveler goals of the world, because of the limitless massiveness of its archeological and creative fortunes, and for the appeal of its one of kind conventions, the excellence of its all-encompassing perspectives, and the superbness of its brilliant "villas"

Target Audience:
Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations Heads and Professors, Research scientists, CNS and neuroscience laboratory heads, Post-docs, Students other affiliates related to the area of Neuroscience research, CNS disorders and therapeutic medicine can be as Target Audience.
Neurology related Societies:
Cyprus Neurological Society
Czech Society of Neurology
Danish Neurological Society
Estonian Society of Neurologists & Neurosurgeons
Finnish Neurological Association
Société Française de Neurologie
Georgian Society of Neurologists
Canadian Neurological Society
Dominican Neurological and Neurosurgical Society
Neurology Society of Argentina
American Academy of Neurology
Panamanian Society of Neurology & Neurosurgery
Ecuadorian Society of Neurology
Honduran Association of Neurology
Bahrain Neurosciences Association
Society of Neurologists of Bangladesh
Chinese Neurological Society
The Hong Kong Neurological Society
Indian Academy of Neurology
Indonesian Neurological Association
Iranian Neurological Association
Organizing Committee
OCM Member
Davide V Moretti
Semmelweiss University
Aviano, Italy
OCM Member
Shams Tabrez
King Abdulaziz University
Jeddah, Saudi Arabia
OCM Member
Fred C. C. Peng
Veterans General Hospital
Tamsui District, Taiwan

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2018
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program enquiry
cns@alliedscholars.com
Sponsors/Exhibiting/Advertising
kate.evans@alliedscholars.com
General Queries
cns@alliedevents.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. Allied Academies Pte. Ltd. is an objective third-party non-profit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact cns@alliedscholars.net or 
cns@alliedevents.org to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account.

This cancellation policy was last updated on April 04, 2015.

Cancellation, Postponement, and Transfer of Registration

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com  

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if registered person is unable to attend the event. Transfers must be made by the registered person in writing to finance@alliedacademies.com. Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-


Before 60 days of the conference: Eligible for Full Refund less $100 Service Fee
 Within 60-30 days of Conference: Eligible for 50% of payment Refund
 Within 30 days of Conference: Not eligible for Refund
E-Poster Payments will not be refunded

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

Authorization Policy

Copyright © 2018-2019 Allied Academies, All Rights Reserved.